NORTH CHICAGO, Ill.,
Nov. 23, 2021 /PRNewswire/
-- AbbVie (NYSE: ABBV) will participate in the 4th
Annual Evercore ISI Virtual HealthCONx Conference on Thursday, December 2, 2021. Michael Severino, M.D., vice chairman and
president, Robert A. Michael,
executive vice president and chief financial officer, and
Jeffrey R. Stewart, executive vice
president, commercial operations, will present at 11:10 a.m. CT.
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the session will be
available later that day.
About AbbVie
AbbVie's mission is to discover and
deliver innovative medicines that solve serious health issues today
and address the medical challenges of tomorrow. We strive to have a
remarkable impact on people's lives across several key therapeutic
areas: immunology, oncology, neuroscience, eye care, virology,
women's health and gastroenterology, in addition to products and
services across its Allergan Aesthetics portfolio. For more
information about AbbVie, please visit us at www.abbvie.com.
Follow @abbvie on Twitter, Facebook, Instagram, YouTube and
LinkedIn.
View original
content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-evercore-isi-conference-301430236.html
SOURCE AbbVie